Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion type Assertion NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_head.
- NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion description "[Therapy-related myelodysplasia and myeloid leukemia (t-MDS/t-AML) is a distinctive clinical syndrome occurring after exposure to chemotherapy (CT) or radiotherapy (RT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_provenance.
- NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion evidence source_evidence_literature NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_provenance.
- NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion SIO_000772 12623843 NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_provenance.
- NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion wasDerivedFrom befree-20150227 NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_provenance.
- NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_assertion wasGeneratedBy ECO_0000203 NP605942.RAG-0P4h4V7lwsNEXCwTs7TqBQbR0IRwPAOpPl342wYjA130_provenance.